- Home
- UNCY vs APYX Comparison
UNCY vs APYX Comparison
Compare UNCY & APYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNCY
- APYX
- Stock Information
- Founded
- UNCY 2016
- APYX 1982
- Country
- UNCY United States
- APYX United States
- Employees
- UNCY N/A
- APYX N/A
- Industry
- UNCY Biotechnology: Pharmaceutical Preparations
- APYX Medical/Dental Instruments
- Sector
- UNCY Health Care
- APYX Health Care
- Exchange
- UNCY Nasdaq
- APYX Nasdaq
- Market Cap
- UNCY 91.0M
- APYX 85.0M
- IPO Year
- UNCY 2021
- APYX 1987
- Fundamental
- Price
- UNCY $4.87
- APYX $2.54
- Analyst Decision
- UNCY Strong Buy
- APYX Hold
- Analyst Count
- UNCY 4
- APYX 2
- Target Price
- UNCY $63.75
- APYX N/A
- AVG Volume (30 Days)
- UNCY 934.5K
- APYX 103.5K
- Earning Date
- UNCY 08-13-2025
- APYX 08-07-2025
- Dividend Yield
- UNCY N/A
- APYX N/A
- EPS Growth
- UNCY N/A
- APYX N/A
- EPS
- UNCY N/A
- APYX N/A
- Revenue
- UNCY N/A
- APYX $47,288,000.00
- Revenue This Year
- UNCY N/A
- APYX $2.25
- Revenue Next Year
- UNCY $1,458.53
- APYX $6.76
- P/E Ratio
- UNCY N/A
- APYX N/A
- Revenue Growth
- UNCY N/A
- APYX N/A
- 52 Week Low
- UNCY $2.02
- APYX $0.76
- 52 Week High
- UNCY $11.00
- APYX $2.73
- Technical
- Relative Strength Index (RSI)
- UNCY 45.55
- APYX 65.15
- Support Level
- UNCY $4.38
- APYX $2.20
- Resistance Level
- UNCY $4.96
- APYX $2.41
- Average True Range (ATR)
- UNCY 0.31
- APYX 0.24
- MACD
- UNCY 0.05
- APYX 0.01
- Stochastic Oscillator
- UNCY 41.88
- APYX 82.35
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.
About APYX Apyx Medical Corporation
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.